BACKGROUND: Large community outbreaks of pandemic A (H1N1) 2009 occurred between October and December 2009 in Mongolia. A serological study was conducted among the general population by testing paired sera collected before and after the first wave of pandemic in Selenghe province, Mongolia. None of the study participants had been vaccinated for pandemic A (H1N1) 2009 before the second samples were collected. OBJECTIVE: The objective of this study was to estimate cumulative incidence of pandemic A (H1N1) 2009 in different age-groups of Selenghe province residents. METHODS: After informed consent was obtained from apparently healthy volunteers, the paired sera and background information were collected. Antibody titers were measured using hemagglutinin inhibition (HI) and microneutralization (MN) assays for A/California/07/2009pdm. A fourfold rise in antibody titers was regarded as the evidence of infection. RESULTS: The overall cumulative incidences in the study group for all ages were 28.8% (76/264) by HI, 35.2% (93/264) by MN, and 25.0% (66/264) by both HI and MN. Cumulative incidences of infection varied among age-groups, with children aged 2-4 and 5-9 years having high cumulative incidence of infection. Overall cumulative incidences of infection in the whole population were estimated to be 23.0% (4946/21460) by HI, 30.2% (6473/21460) by MN, and 18.8% (4036/21460) by both HI and MN. CONCLUSIONS: This study indicates that about one-fourth of the total population in Selenghe province was infected with pandemic A (H1N1) 2009 virus during the first wave of the pandemic.
BACKGROUND: Large community outbreaks of pandemic A (H1N1) 2009 occurred between October and December 2009 in Mongolia. A serological study was conducted among the general population by testing paired sera collected before and after the first wave of pandemic in Selenghe province, Mongolia. None of the study participants had been vaccinated for pandemic A (H1N1) 2009 before the second samples were collected. OBJECTIVE: The objective of this study was to estimate cumulative incidence of pandemic A (H1N1) 2009 in different age-groups of Selenghe province residents. METHODS: After informed consent was obtained from apparently healthy volunteers, the paired sera and background information were collected. Antibody titers were measured using hemagglutinin inhibition (HI) and microneutralization (MN) assays for A/California/07/2009pdm. A fourfold rise in antibody titers was regarded as the evidence of infection. RESULTS: The overall cumulative incidences in the study group for all ages were 28.8% (76/264) by HI, 35.2% (93/264) by MN, and 25.0% (66/264) by both HI and MN. Cumulative incidences of infection varied among age-groups, with children aged 2-4 and 5-9 years having high cumulative incidence of infection. Overall cumulative incidences of infection in the whole population were estimated to be 23.0% (4946/21460) by HI, 30.2% (6473/21460) by MN, and 18.8% (4036/21460) by both HI and MN. CONCLUSIONS: This study indicates that about one-fourth of the total population in Selenghe province was infected with pandemic A (H1N1) 2009 virus during the first wave of the pandemic.
Authors: Mark I C Chen; Vernon J M Lee; Wei-Yen Lim; Ian G Barr; Raymond T P Lin; Gerald C H Koh; Jonathan Yap; Lin Cui; Alex R Cook; Karen Laurie; Linda W L Tan; Boon Huan Tan; Jimmy Loh; Robert Shaw; Chris Durrant; Vincent T K Chow; Anne Kelso; Kee Seng Chia; Yee Sin Leo Journal: JAMA Date: 2010-04-14 Impact factor: 56.272
Authors: N Ikonen; M Strengell; L Kinnunen; P Osterlund; J Pirhonen; M Broman; I Davidkin; T Ziegler; I Julkunen Journal: Euro Surveill Date: 2010-02-04
Authors: Julian W Tang; Paul A Tambyah; Annelies Wilder-Smith; Kim Yoong Puong; Robert Shaw; Ian G Barr; Kwai Peng Chan Journal: Emerg Infect Dis Date: 2010-05 Impact factor: 6.883
Authors: Gwendolyn L Gilbert; Michelle A Cretikos; Linda Hueston; George Doukas; Brian O'Toole; Dominic E Dwyer Journal: PLoS One Date: 2010-09-07 Impact factor: 3.240
Authors: Elizabeth Miller; Katja Hoschler; Pia Hardelid; Elaine Stanford; Nick Andrews; Maria Zambon Journal: Lancet Date: 2010-01-21 Impact factor: 79.321
Authors: Simon Cauchemez; Alain-Jacques Valleron; Pierre-Yves Boëlle; Antoine Flahault; Neil M Ferguson Journal: Nature Date: 2008-04-10 Impact factor: 49.962
Authors: Mark I Chen; Ian G Barr; Gerald C H Koh; Vernon J Lee; Caroline P S Lee; Robert Shaw; Cui Lin; Jonathan Yap; Alex R Cook; Boon Huan Tan; Jin Phang Loh; Timothy Barkham; Vincent T K Chow; Raymond T P Lin; Yee-Sin Leo Journal: PLoS One Date: 2010-08-30 Impact factor: 3.240
Authors: Nyamdavaa Khurelbaatar; Whitney S Krueger; Gary L Heil; Badarchiin Darmaa; Daramragchaa Ulziimaa; Damdindorj Tserennorov; Ariungerel Baterdene; Benjamin D Anderson; Gregory C Gray Journal: PLoS One Date: 2014-01-21 Impact factor: 3.240
Authors: Maria D Van Kerkhove; Siddhivinayak Hirve; Artemis Koukounari; Anthony W Mounts Journal: Influenza Other Respir Viruses Date: 2013-01-21 Impact factor: 4.380